---
title: "FDA Issues Early Alert For Medtronic's Esophageal pH Monitoring Capsule Delivery Device"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297208248.md"
datetime: "2026-08-27T15:26:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297208248.md)
  - [en](https://longbridge.com/en/news/297208248.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297208248.md)
generator: "portal-rs"
---

# FDA Issues Early Alert For Medtronic's Esophageal pH Monitoring Capsule Delivery Device

Aug 27 (Reuters) - US FDA: \* FDA: ISSUING EARLY ALERT FOR ESOPHAGEAL PH MONITORING CAPSULE DELIVERY DEVICE ISSUE FROM MEDTRONIC AND GIVEN IMAGING \* FDA: AS OF AUG 10, MEDTRONIC HAS REPORTED 184 SERIOUS INJURIES & NO DEATHS ASSOCIATED WITH ESOPHAGEAL PH MONITORING CAPSULE DELIVERY DEVICE ISSUE Further company coverage: (MDT.N)

### Related Stocks

- [MDT.US](https://longbridge.com/en/quote/MDT.US.md)

## Related News & Research

- [Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call](https://longbridge.com/en/news/297311060.md)
- [Medtronic Q1 earnings on deck: What to expect](https://longbridge.com/en/news/297548654.md)
- [CELESC opens tender for meter-reading, bill printing and delivery services in Lot 02](https://longbridge.com/en/news/297012409.md)
- [Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing](https://longbridge.com/en/news/297194419.md)
- [Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™ | NTRA Stock News](https://longbridge.com/en/news/297164196.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**